Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis after 7/8 matched unrelated hematopoietic cell transplantation
2017-003530-85Phase 2Completed
- Sponsor
- GITMO
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), sponsored by GITMO. Started Jun 2021; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on 2017-003530-85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003530-85.